Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
475 hedge funds and large institutions have $7.66B invested in Exact Sciences in 2020 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 181 increasing their positions, 152 reducing their positions, and 114 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 181 | Existing positions reduced: 152
0.57% more ownership
Funds ownership: 88.54% → 89.11% (+0.57%)
10% less funds holding
Funds holding: 527 → 475 (-52)
19% less call options, than puts
Call options by funds: $119M | Put options by funds: $147M
36% less capital invested
Capital invested by funds: $12.1B → $7.66B (-$4.4B)
38% less funds holding in top 10
Funds holding in top 10: 13 → 8 (-5)
41% less first-time investments, than exits
New positions opened: 67 | Existing positions closed: 114
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$250M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$125M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$73.5M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$72.8M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$340M |
| 2 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$228M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$87M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$60M |
| 5 |
CCM
Consonance Capital Management
New York
|
-$53.6M |
EXAS Hedge Fund Activity: Q1 2020 in Review
475 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2020, worth a combined $7.66B — down 36% from $12.1B a quarter earlier.
Sellers outnumbered buyers: 114 funds closed out of EXAS and 67 opened new positions — a net loss of 47 holders — while 152 trimmed existing stakes and 181 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $250M. The largest seller was Jennison Associates, cutting an estimated $340M.
- 475 institutional investors held Exact Sciences (EXAS) as of Q1 2020, down from 527 in Q4 2019.
- Funds reported $7.66B of Exact Sciences stock for Q1 2020, down 36% quarter-over-quarter.
- 67 funds opened new Exact Sciences positions in Q1 2020 and 114 closed out, a net change of -47 holders.
- The largest Exact Sciences buyer in Q1 2020 was T. Rowe Price Associates, an estimated $250M added.
- The largest Exact Sciences seller in Q1 2020 was Jennison Associates, an estimated $340M sold.
Based on aggregated 13F filings for Q1 2020.